COMPANY
Oncosynergy, Inc.
Funding and NIH signals
- SEC Form D raise Raised $6.61M (Form D filed May 26, 2026). SEC Form D 0001556747-26-000003 (May 26, 2026)
Evidence (1 event)
- May 26, 2026 · SEC Form D 0001556747-26-000003
Name of Issuer: ONCOSYNERGY, INC.; CIK: 1556747; Address: Stamford, CT; Submission type: D; Filing date: 2026-05-26; Industry Group: Biotechnology; Date of First Sale: 2026-05-11; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 8208830; Total Amount Sold: 6608832; Federal exemptions: 06b
- May 26, 2026 · SEC Form D 0001556747-26-000003
Timeline
- Trial start Phase 1: Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT04608812 | Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection | Phase 1 | Terminated | Mar 2, 2021 | Feb 27, 2023 (actual) |